References
1. Titulaer, M.J. et al. Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis. Annals of neurology 75 , 411-428 (2014).
2. Comi, G., Radaelli, M. & Soelberg Sørensen, P. Evolving concepts in the treatment of relapsing multiple sclerosis. Lancet (London, England) 389 , 1347-1356 (2017).
3. Shi, H. et al. NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component.Nature immunology 17 , 250-258 (2016).
4. Chivero, E.T. et al. HIV-1 Tat Primes and Activates Microglial NLRP3 Inflammasome-Mediated Neuroinflammation. The Journal of neuroscience : the official journal of the Society for Neuroscience37 , 3599-3609 (2017).
5. Rathinam, V.A. & Fitzgerald, K.A. Inflammasome Complexes: Emerging Mechanisms and Effector Functions. Cell 165 , 792-800 (2016).
6. Miao, E.A., Rajan, J.V. & Aderem, A. Caspase-1-induced pyroptotic cell death. Immunological reviews 243 , 206-214 (2011).
7. Gris, D. et al. NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses. Journal of immunology (Baltimore, Md. : 1950)185 , 974-981 (2010).
8. Inoue, M., Williams, K.L., Gunn, M.D. & Shinohara, M.L. NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis. Proceedings of the National Academy of Sciences of the United States of America109 , 10480-10485 (2012).
9. Halle, A. et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nature immunology9 , 857-865 (2008).
10. Seppi, D. et al. Cerebrospinal fluid IL-1β correlates with cortical pathology load in multiple sclerosis at clinical onset.Journal of neuroimmunology 270 , 56-60 (2014).
11. Hauptmann, J. et al. Interleukin-1 promotes autoimmune neuroinflammation by suppressing endothelial heme oxygenase-1 at the blood-brain barrier. Acta neuropathologica 140 , 549-567 (2020).
12. Mellergård, J., Edström, M., Vrethem, M., Ernerudh, J. & Dahle, C. Natalizumab treatment in multiple sclerosis: marked decline of chemokines and cytokines in cerebrospinal fluid. Multiple sclerosis (Houndmills, Basingstoke, England) 16 , 208-217 (2010).
13. Carpintero, R. & Burger, D. IFNβ and glatiramer acetate trigger different signaling pathways to regulate the IL-1 system in multiple sclerosis. Communicative & integrative biology 4 , 112-114 (2011).
14. Garris, C.S. et al. Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation. Nature immunology 14 , 1166-1172 (2013).
15. Wang, X. et al. OTUB1 inhibits CNS autoimmunity by preventing IFN-γ-induced hyperactivation of astrocytes. The EMBO journal38 (2019).
16. Damsky, W. et al. The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases.The Journal of allergy and clinical immunology 147 , 814-826 (2021).
17. Baker, K.F. & Isaacs, J.D. Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn’s disease and ulcerative colitis? Annals of the rheumatic diseases 77 , 175-187 (2018).
18. Oetjen, L.K. et al. Sensory Neurons Co-opt Classical Immune Signaling Pathways to Mediate Chronic Itch. Cell 171 , 217-228.e213 (2017).
19. Hussain, M. et al. Basophil-derived IL-4 promotes epicutaneous antigen sensitization concomitant with the development of food allergy. The Journal of allergy and clinical immunology141 , 223-234.e225 (2018).
20. Corren, J. & Ziegler, S.F. TSLP: from allergy to cancer.Nature immunology 20 , 1603-1609 (2019).
21. Liang, Y. et al. Thymic stromal lymphopoietin epigenetically upregulates Fc receptor γ subunit-related receptors on antigen-presenting cells and induces T(H)2/T(H)17 polarization through dectin-2. The Journal of allergy and clinical immunology144 , 1025-1035.e1027 (2019).
22. Gregory, S.G. et al. Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis.Nature genetics 39 , 1083-1091 (2007).
23. Samoilova, E.B., Horton, J.L., Hilliard, B., Liu, T.S. & Chen, Y. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. Journal of immunology (Baltimore, Md. : 1950) 161 , 6480-6486 (1998).
24. Duong, T.T., St Louis, J., Gilbert, J.J., Finkelman, F.D. & Strejan, G.H. Effect of anti-interferon-gamma and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse. Journal of neuroimmunology 36 , 105-115 (1992).
25. Baker, D. et al. Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins. European journal of immunology 24 , 2040-2048 (1994).
26. Hartgring, S.A. et al. Critical proinflammatory role of thymic stromal lymphopoietin and its receptor in experimental autoimmune arthritis. Arthritis and rheumatism 63 , 1878-1887 (2011).
27. Furuya, M.Y. et al. Tofacitinib inhibits granulocyte-macrophage colony-stimulating factor-induced NLRP3 inflammasome activation in human neutrophils. Arthritis research & therapy 20 , 196 (2018).
28. Graus, F. et al. A clinical approach to diagnosis of autoimmune encephalitis. The Lancet. Neurology 15 , 391-404 (2016).
29. Lévesque, S.A. et al. Myeloid cell transmigration across the CNS vasculature triggers IL-1β-driven neuroinflammation during autoimmune encephalomyelitis in mice. The Journal of experimental medicine 213 , 929-949 (2016).
30. Coll, R.C. et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nature medicine 21 , 248-255 (2015).
31. Fleischman, A.G. et al. The CSF3R T618I mutation causes a lethal neutrophilic neoplasia in mice that is responsive to therapeutic JAK inhibition. Blood 122 , 3628-3631 (2013).
32. Lin, X.L. et al. Heme oxygenase-1 directly binds STAT3 to control the generation of pathogenic Th17 cells during neutrophilic airway inflammation. Allergy 72 , 1972-1987 (2017).
33. Paré, A. et al. IL-1β enables CNS access to CCR2(hi) monocytes and the generation of pathogenic cells through GM-CSF released by CNS endothelial cells. Proceedings of the National Academy of Sciences of the United States of America 115 , E1194-e1203 (2018).
34. Damasceno, L.E.A. et al. PKM2 promotes Th17 cell differentiation and autoimmune inflammation by fine-tuning STAT3 activation. The Journal of experimental medicine 217(2020).
35. Wu, B. et al. The TGF-β superfamily cytokine Activin-A is induced during autoimmune neuroinflammation and drives pathogenic Th17 cell differentiation. Immunity 54 , 308-323.e306 (2021).
36. Ciccia, F. et al. Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis.Annals of the rheumatic diseases 74 , 1739-1747 (2015).
37. Hatfield, J.K. & Brown, M.A. Group 3 innate lymphoid cells accumulate and exhibit disease-induced activation in the meninges in EAE. Cellular immunology 297 , 69-79 (2015).
38. Lv, J. et al. Airway epithelial TSLP production of TLR2 drives type 2 immunity in allergic airway inflammation. European journal of immunology 48 , 1838-1850 (2018).
39. Martínez-López, M. et al. Microbiota Sensing by Mincle-Syk Axis in Dendritic Cells Regulates Interleukin-17 and -22 Production and Promotes Intestinal Barrier Integrity. Immunity 50 , 446-461.e449 (2019).
40. Haas, J., Korporal, M., Schwarz, A., Balint, B. & Wildemann, B. The interleukin-7 receptor α chain contributes to altered homeostasis of regulatory T cells in multiple sclerosis. European journal of immunology 41 , 845-853 (2011).
41. Eckhardt, J. et al. Thymic stromal lymphopoietin deficiency attenuates experimental autoimmune encephalomyelitis. Clinical and experimental immunology 181 , 51-64 (2015).
42. Lee, H.C. et al. Hepatitis C virus promotes T-helper (Th)17 responses through thymic stromal lymphopoietin production by infected hepatocytes. Hepatology (Baltimore, Md.) 57 , 1314-1324 (2013).
43. Hirota, K. et al. Autoimmune Th17 Cells Induced Synovial Stromal and Innate Lymphoid Cell Secretion of the Cytokine GM-CSF to Initiate and Augment Autoimmune Arthritis. Immunity 48 , 1220-1232.e1225 (2018).
44. Suto, H. et al. IL-25 enhances T(H)17 cell-mediated contact dermatitis by promoting IL-1β production by dermal dendritic cells.The Journal of allergy and clinical immunology 142 , 1500-1509.e1510 (2018).
45. Wilson, S.R. et al. The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch. Cell155 , 285-295 (2013).
46. Mishra, S.K. et al. Periostin Activation of Integrin Receptors on Sensory Neurons Induces Allergic Itch. Cell reports31 , 107472 (2020).
47. Kitic, M. et al. Thymic stromal lymphopoietin is expressed in the intact central nervous system and upregulated in the myelin-degenerative central nervous system. Glia 62 , 1066-1074 (2014).
48. Hodecker, S.C. et al. Ruxolitinib treatment in a patient with neuromyelitis optica: A case report. Neurology(R) neuroimmunology & neuroinflammation 4 , e328 (2017).
49. Wallace, D.J. et al. Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet (London, England) 392 , 222-231 (2018).
50. van der Heijde, D. et al. Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study. Annals of the rheumatic diseases 76 , 1340-1347 (2017).
51. Schattling, B. et al. TRPM4 cation channel mediates axonal and neuronal degeneration in experimental autoimmune encephalomyelitis and multiple sclerosis. Nature medicine 18 , 1805-1811 (2012).
52. Fang, D. et al. Interleukin-6-mediated functional upregulation of TRPV1 receptors in dorsal root ganglion neurons through the activation of JAK/PI3K signaling pathway: roles in the development of bone cancer pain in a rat model. Pain 156 , 1124-1144 (2015).
53. Malsch, P. et al. Deletion of interleukin-6 signal transducer gp130 in small sensory neurons attenuates mechanonociception and down-regulates TRPA1 expression. The Journal of neuroscience : the official journal of the Society for Neuroscience 34 , 9845-9856 (2014).
54. Torke, S. et al. Inhibition of Bruton’s tyrosine kinase interferes with pathogenic B-cell development in inflammatory CNS demyelinating disease. Acta neuropathologica 140 , 535-548 (2020).
55. Montalban, X. et al. Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple Sclerosis. The New England journal of medicine 380 , 2406-2417 (2019).